ivabradine has been researched along with Complications of Diabetes Mellitus in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, A | 1 |
| Böhm, M; Borer, JS; Ford, I; Francq, BG; Komajda, M; Swedberg, K; Tavazzi, L | 1 |
| Ferrari, R; Ford, I; Fox, K; Steg, PG; Tendera, M | 1 |
| Riccioni, G | 1 |
2 review(s) available for ivabradine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Heart Failure.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Cardiac Rehabilitation; Cardiovascular Agents; Coronary Artery Disease; Defibrillators, Implantable; Diabetes Complications; Diagnostic Techniques, Cardiovascular; Digoxin; Diuretics; Heart Failure; Hospitalization; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Ivabradine; Life Style; Mineralocorticoid Receptor Antagonists; Palliative Care; Primary Prevention; Referral and Consultation; Risk Factors | 2018 |
Ivabradine: from molecular basis to clinical effectiveness.
Topics: Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Diabetes Complications; Heart Rate; Humans; Ivabradine; Sinoatrial Node; Ventricular Remodeling | 2010 |
2 trial(s) available for ivabradine and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial.
Topics: Benzazepines; Cardiovascular Agents; Diabetes Complications; Female; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Prognosis | 2015 |
The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction - baseline characteristics of the study population.
Topics: Aged; Benzazepines; Cardiovascular Agents; Coronary Artery Disease; Diabetes Complications; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Ivabradine; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Ventricular Dysfunction, Left | 2008 |